159 related articles for article (PubMed ID: 6339496)
1. Regulation of extracellular plasminogen activator by human fibroblasts. The role of protease nexin.
Scott RW; Eaton DL; Duran N; Baker JB
J Biol Chem; 1983 Apr; 258(7):4397-403. PubMed ID: 6339496
[TBL] [Abstract][Full Text] [Related]
2. Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin.
Eaton DL; Scott RW; Baker JB
J Biol Chem; 1984 May; 259(10):6241-7. PubMed ID: 6373753
[TBL] [Abstract][Full Text] [Related]
3. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.
Baker JB; Low DA; Simmer RL; Cunningham DD
Cell; 1980 Aug; 21(1):37-45. PubMed ID: 6157479
[TBL] [Abstract][Full Text] [Related]
4. Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin.
Eaton DL; Baker JB
J Cell Biol; 1983 Aug; 97(2):323-8. PubMed ID: 6224800
[TBL] [Abstract][Full Text] [Related]
5. Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases.
Low DA; Baker JB; Koonce WC; Cunningham DD
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2340-4. PubMed ID: 7017731
[TBL] [Abstract][Full Text] [Related]
6. Regulation of protease nexin-1 target protease specificity by collagen type IV.
Donovan FM; Vaughan PJ; Cunningham DD
J Biol Chem; 1994 Jun; 269(25):17199-205. PubMed ID: 8006028
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of urokinase and thrombin in cultured neural cells.
Wagner SL; Lau AL; Nguyen A; Mimuro J; Loskutoff DJ; Isackson PJ; Cunningham DD
J Neurochem; 1991 Jan; 56(1):234-42. PubMed ID: 1987320
[TBL] [Abstract][Full Text] [Related]
8. Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases.
Knauer DJ; Thompson JA; Cunningham DD
J Cell Physiol; 1983 Dec; 117(3):385-96. PubMed ID: 6317700
[TBL] [Abstract][Full Text] [Related]
9. A fibroblast-derived urokinase-inhibitor differing from protease nexin.
Masuzawa M; Hamazaki H; Nishioka K; Nishiyama S; Ryan TJ
Biochem Biophys Res Commun; 1987 Dec; 149(3):866-73. PubMed ID: 3426613
[TBL] [Abstract][Full Text] [Related]
10. Cryptic urokinase binding sites on human foreskin fibroblasts.
Bajpai A; Baker JB
Biochem Biophys Res Commun; 1985 Dec; 133(2):475-82. PubMed ID: 3002345
[TBL] [Abstract][Full Text] [Related]
11. Serpin inhibitors of urokinase and thrombin in normal rat brain and the 9L brain tumor: evidence for elevated expression of protease nexin I-like inhibitor and a novel sodium dodecyl sulfate-activated tumor antithrombin.
Rao JS; Baker JB; Morantz RA; Kimler B; Evans R; Festoff BW
Cancer Res; 1990 Aug; 50(16):5039-44. PubMed ID: 2116223
[TBL] [Abstract][Full Text] [Related]
12. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
Philips M; Juul AG; Thorsen S
Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
[TBL] [Abstract][Full Text] [Related]
13. Evidence that a variety of cultured cells secrete protease nexin and produce a distinct cytoplasmic serine protease-binding factor.
Eaton DL; Baker JB
J Cell Physiol; 1983 Nov; 117(2):175-82. PubMed ID: 6579053
[TBL] [Abstract][Full Text] [Related]
14. Protease nexin I, a serpin, inhibits plasminogen-dependent degradation of muscle extracellular matrix.
Rao JS; Kahler CB; Baker JB; Festoff BW
Muscle Nerve; 1989 Aug; 12(8):640-6. PubMed ID: 2506447
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
16. Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I.
Rosenblatt DE; Cotman CW; Nieto-Sampedro M; Rowe JW; Knauer DJ
Brain Res; 1987 Jul; 415(1):40-8. PubMed ID: 3040175
[TBL] [Abstract][Full Text] [Related]
17. Coordinated and cell-specific induction of both physiological plasminogen activators creates functionally redundant mechanisms for plasmin formation during ovulation.
Hägglund AC; Ny A; Liu K; Ny T
Endocrinology; 1996 Dec; 137(12):5671-7. PubMed ID: 8940398
[TBL] [Abstract][Full Text] [Related]
18. The Role of Fibrinolytic System in Health and Disease.
Kwaan HC
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
[TBL] [Abstract][Full Text] [Related]
19. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
Del Rosso M; Dini G; Fibbi G
Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
